105
Views
4
CrossRef citations to date
0
Altmetric
Original Research

Cancer prevalence among the rural poverty-stricken population in Northeast China

, , , , , , , , , , , , & show all
Pages 5101-5112 | Published online: 31 May 2019

References

  • Zeng H, Chen W, Zheng R, et al. Changing cancer survival in China during 2003–15: a pooled analysis of 17 population-based cancer registries. Lancet Glob Health. 2018;6:e555–e67. doi:10.1016/S2214-109X(18)30127-X29653628
  • Bray F, Ferlay J, Soerjomataram I, et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68:394–424. Epub 2018 Sep 12. doi:10.3322/caac.2149230207593
  • Chen W, Zheng R, Baade PD, et al. Cancer statistics in China, 2015. CA Cancer J Clin. 2016;66:115–132. doi:10.3322/caac.2133826808342
  • Chen W, Zheng R, Zhang S, et al. Cancer incidence and mortality in China, 2013. Cancer Lett. 2017;401:63–71. doi:10.1016/j.canlet.2017.04.02428476483
  • National Bureau of Statistics of China. China Statistical Yearbook, 2018. Beijing, China: China Statistics Press; 2016 Available from: http://www.stats.gov.cn/tjsj/ndsj/2018/indexeh.htm. Accessed October 5, 2018.
  • Zheng R, Zeng H, Zhang S, Chen T, Chen W. National estimates of cancer prevalence in China, 2011. Cancer Lett. 2016;370:33–38. doi:10.1016/j.canlet.2015.10.00326458996
  • Colonna M, Danzon A, Delafosse P, et al. Cancer prevalence in France: time trend, situation in 2002 and extrapolation to 2012. Eur J Cancer. 2008;44:115–122. doi:10.1016/j.ejca.2007.10.02218032021
  • Colonna M, Boussari O, Cowppli-Bony A, et al. Time trends and short term projections of cancer prevalence in France. Cancer Epidemiol. 2018;56:97–105. doi:10.1016/j.canep.2018.08.00130125884
  • Maddams J, Utley M, Moller H. Projections of cancer prevalence in the United Kingdom, 2010–2040. Br J Cancer. 2012;107:1195–1202. doi:10.1038/bjc.2012.36622892390
  • Jung KW, Won YJ, Kong HJ, Lee ES. Cancer statistics in Korea: incidence, mortality, survival, and prevalence in 2015. Cancer Res Treat. 2018;50:303–316. doi:10.4143/crt.2018.14329566481
  • Nolen SC, Evans MA, Fischer A, Corrada MM, Kawas CH, Bota DA. Cancer—incidence, prevalence and mortality in the oldest-old. A comprehensive review. Mech Ageing Dev. 2017;164:113–126. doi:10.1016/j.mad.2017.05.00228502820
  • Hoang VM, Pham CP, Vu QM, et al. Household financial burden and poverty impacts of cancer treatment in Vietnam. Biomed Res Int. 2017;2017:1–8.
  • Forman D, Sierra MS. Cancer in Central and South America: introduction. Cancer Epidemiol. 2016;44:S3–10. doi:10.1016/j.canep.2016.04.00827678321
  • Maxwell S, O’Leary P, Slevin T, Moorin R. The increase in cancer prevalence and hospital burden in Western Australia, 1992–2011. Popul Health Metr. 2014;12:33. doi:10.1186/s12963-014-0033-x25649152
  • Aue K, Roosen J, Jensen HH. Poverty dynamics in Germany: evidence on the relationship between persistent overty and health behavior. Soc Sci Med. 2016;153:62–70. doi:10.1016/j.socscimed.2016.01.04026874825
  • Porter J. Poverty, disease, and urban governance in late nineteenth-century Osaka. City, Cult Soc. 2012;3:73–78. doi:10.1016/j.ccs.2012.06.005
  • Menon J, Vijaykumar N, Joseph JK, et al. Below the poverty line and non-communicable diseases in Kerala: the epidemiology of non-communicable diseases in rural areas (ENDIRA) study. Int J Cardiol. 2015;187:519–524. doi:10.1016/j.ijcard.2015.04.00925846664
  • Pou SA, Tumas N, Soria DS, Ortiz P, del Pilar Diaz M. Large-scale societal factors and noncommunicable diseases: urbanization, poverty and mortality spatial patterns in Argentina. Appl Geogr. 2017;86:32–40. doi:10.1016/j.apgeog.2017.06.022
  • de Grubb MCM, Kilbourne B, Kilbourne K, et al. Socioeconomic, environmental, and geographic factors and US lung cancer mortality, 1999–2009. Fam Med Community Health. 2017;5:3–12. doi:10.15212/FMCH.2017.0108
  • Luengo-Fernandez R, Leal J, Gray A, Sullivan R. Economic burden of cancer across the European Union: a population-based cost analysis. Lancet Oncol. 2013;14:1165–1174. doi:10.1016/S1470-2045(13)70442-X24131614
  • Guy GP J, Yabroff KR, Ekwueme DU, et al. Healthcare expenditure burden among non-elderly cancer survivors. 2008–2012. Amer J Prev Med. 2015;49:S489–97. doi:10.1016/j.amepre.2015.09.00226590644
  • Gilligan AM, Alberts DS, Roe DJ, Skrepnek GH. Death or debt? National estimates of financial toxicity in persons with newly-diagnosed cancer. Amer J Med. 2018;131:1187–99.e5.23. doi:10.1016/j.amjmed.2017.12.01729906429
  • Chen W, Xia C, Zheng R, et al. Disparities by province, age, and sex in site-specific cancer burden attributable to 23 potentially modifiable risk factors in China: a comparative risk assessment. Lancet Glob Health. 2019;7:e257–69. doi:10.1016/S2214-109X(19)30013-030683243
  • Popat K, McQueen K, Feeley TW. The global burden of cancer. Best Pract Res Clin Anaesthesiol. 2013;27:399–408. doi:10.1016/j.bpa.2013.10.01024267547
  • Torre LA, Bray F, Siegel RL, Ferlay J, Lortet-Tieulent J, Jemal A. Global cancer statistics, 2012. CA Cancer J Clin. 2015;65:87–108. doi:10.3322/caac.2129425651787
  • Nakagawa-Senda H, Yamaguchi M, Matsuda T, et al. Cancer prevalence in Aichi, Japan for 2012: estimates based on incidence and survival data from population-based cancer registry. Asian Pac J Cancer Prev. 2017;18:2151–2156. doi:10.22034/APJCP.2017.18.1.2328843249
  • Wang W, Wang X, Liu J, et al. Breast cancer in young women of Chinese Han population: a retrospective study of patients under 25 years. Pathol Res Pract. 2016;212:1015–1020. doi:10.1016/j.prp.2016.08.01027712977
  • Erdmann F, Li T, Luta G, et al. Incidence of childhood cancer in Costa Rica, 2000–2014: an international perspective. Cancer Epidemiol. 2018;56:21–30. doi:10.1016/j.canep.2018.07.00430025251
  • Gandhi AK, Kumar P, Bhandari M, Devnani B, Rath GK. Burden of preventable cancers in India: time to strike the cancer epidemic. J Egypt Natl Can Inst. 2017;29:11–18. doi:10.1016/j.jnci.2016.08.002
  • Li Y, Sun Y, Zhang Y, Yi D, Ma C, Ma S. Rural–urban disparity in health care: observations from Suzhou, China. Public Health. 2016;138:164–167. doi:10.1016/j.puhe.2016.03.02627137871
  • Li L. The challenges of healthcare reforms in China. Public Health. 2011;125(1):6–8. doi:10.1016/j.puhe.2010.10.01021168176
  • Pan J, Qin X, Li Q, Messinad JP, Delamater PL. Does hospital competition improve health care delivery in China? China Econ Rev. 2015;33:179–199. doi:10.1016/j.chieco.2015.02.002
  • Yang M. Demand for social health insurance: evidence from the Chinese new rural cooperative medical scheme. China Econ Rev. 2018;52:126–135. doi:10.1016/j.chieco.2018.06.004
  • Younger DS. Health care in China. Neurol Clin. 2016;34(4):1115–1125. doi:10.1016/j.ncl.2016.06.00327719993